Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 9, 2022
- Revision received May 19, 2022
- Accepted May 20, 2022
- Published online May 31, 2022.
Copyright & Usage
Copyright © 2022 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).
Author Information
- DIRK RADES1⇑,
- CARLOS A. NARVAEZ1,
- LIESA DZIGGEL1,
- LAURA SPLETTSTÖSSER1,
- STEFAN JANSSEN1,
- DENISE OLBRICH2,
- STEVEN E. SCHILD3,
- SØREN TVILSTED4 and
- TROELS W. KJAER5
- 1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany;
- 2The Centre for Clinical Trials Lübeck, University of Lübeck, Lübeck, Germany;
- 3Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ, U.S A.;
- 4Research Projects and Clinical Optimization, Zealand University Hospital, Køge, Denmark;
- 5Neurological Department, Zealand University Hospital, Roskilde, Denmark
- Correspondence to: Prof. Dirk Rades, MD, Department of Radiation Oncology, University of Lübeck, Ratzeburger Allee 160, 23562 Lübeck, Germany. Tel: +49 45150045401, Fax: +49 45150045404, e-mail: dirk.rades{at}uksh.de